IND_2016-2017_TBSNP-IE_v01_M
Tuberculosis Social Network Project Impact Evaluation 2016-2017
Name | Country code |
---|---|
India | IND |
1-2-3 Survey, phase 2 [hh/123-2]
This impact evaluation took place between January 2016 and October 2017. It consists of a baseline survey and an endline survey. Both surveys are documented here.
Sample survey data [ssd]
Individuals
v2.1: Edited, anonymous dataset for public distribution
This study covers the following topics:
Baseline Survey: includes questions about demographics, household information, respondent/child TB test and/or treatment, social contacts, and the referral scheme
Endline Survey: includes questions about TB treatment, the referral scheme, and mental health
Referral Survey: includes questions about demographics, household information, the referral scheme, respondent/child TB test and/or treatment, social contacts, the interaction with the provider at the health centre, and mental health
New Patient Survey: includes questions about demographics, household information, respondent/child TB test and/or treatment, social contacts, the interaction with the provider at the health centre, and mental health
10 cities across three states (Delhi National Capital Region, Madhya Pradesh, and Rajasthan)
City
Operation ASHA patients receiving treatment for drug-susceptible TB who were at least two weeks into their course of medication when the baseline surveys commenced. The sample was expanded to include patients who had completed their six-month treatment in the three months before the start of the baseline surveys as well.
Name | Affiliation |
---|---|
Jessica Goldberg | University of Maryland |
Mario Macis | Johns Hopkins University |
Pradeep Chintagunta | University of Chicago |
Name | Affiliation |
---|---|
Strategic Impact Evaluation Fund | The World Bank Group |
Name |
---|
Strategic Impact Evaluation Fund |
This study consisted of a randomized controlled trial implemented in 122 Directly Observed Treatment Short Course (DOTS) centers in 10 cities across three states (Delhi National Capital Region, Madhya Pradesh, and Rajasthan). The intervention was implemented by JPAL-South Asia in five waves between January 2016 and October 2017.
We augmented Operation ASHA's established use of community health workers and DOTS treatment by incorporating various types of referrals of new suspects by existing patients. Specifically, we used a cross-randomized design to test, respectively, three types of incentives for referrals and three types of outreach to prospective TB patients. The baseline sample included all Operation ASHA patients receiving treatment for drug-susceptible TB who were at least two weeks into their medication course when the baseline surveys commenced. We expanded the sample to include patients who had completed their six-month treatment in the three months before the start of the baseline surveys. Existing patients were either in the intensive phase (IP) of treatment, where they came to the clinic three times per week, or in the continuing phase (CP) of treatment (typically following IP), which required them to come to the clinic once a week. In cases where the patient was a minor, the survey questions and interventions were addressed to the legal guardian. The experiment was rolled out in five waves between March 2016 and October 2017. To address the possibility of spillover effects between patients, we randomized by center. A total of 3,176 patients were included in our study.
Four survey instruments were used for this study:
Baseline Survey:
Endline Survey:
New Patient Survey:
Referral Survey:
The questionnaires are provided in English and Hindi and are made available for download.
Start | End | Cycle |
---|---|---|
2016-01 | 2017-10 | Baseline and Endline |
Name |
---|
The Abdul Latif Jameel Poverty Action Lab |
For treatment and control centers, each existing patient was visited by a survey enumerator in a private location such as the patient's home. Enumerators obtained informed consent and administered a baseline survey. Information was collected on the existing patient's socioeconomic characteristics, physical and psychological health, and TB treatment, as well as on information-sharing networks. At the end of the survey, patients at treatment and control centers were prompted to think about individuals outside their households who they believed might be affected by TB ("Please think of people you know who have TB symptoms.") According to RNTCP protocol, immediate family members of TB patients are automatically tested for TB, and as such, were excluded from our referral schemes because they were already known to the system. Then, for treatment centers only, all patients were told, "We are promoting outreach for tuberculosis to encourage more people to get tested and treated, and we invite you to join this effort." They could do this by recommending TB testing for people they knew socially and believed to have symptoms; these new suspects would receive referral cards with information about the screening process. The cards contained information about Operation ASHA, names and addresses of local providers and treatment clinics, a list of TB symptoms, and an ID number used by Operation ASHA and the research team to link the card to the referrer and to distribute incentives according to the study design. New suspects were asked to bring these referral cards to Operation ASHA centers, where they would be screened by health providers and sent for further testing (if required) as per RNTCP mandates.
This process, from a suspect's arrival at an Operation ASHA health center to testing and, if necessary, treatment, was recorded in a referral register at the center that was updated with the relevant outcome at each step, including the result of the screening, whether the new symptomatic got tested, the results of the test (for symptomatics who got tested), and whether the newly identified TB-positive individual enrolled in treatment.
New suspects were always told that they had been targeted for outreach by someone who knew them personally, and shown where their information would be recorded on the card that linked them back to the contact who provided the referral. While they were asked to bring referral cards with them to Operation ASHA, they - like any other individual - could seek care at Operation ASHA (or a public sector facility) without providing a referral card or other documentation. Operation ASHA continued to conduct outreach, screening, and enrollment of new patients following its regular procedures throughout the duration of the study, including enrolling new patients who did not have referral cards. Any new suspect who was approached by or on behalf of an existing patient in this study, but who was concerned about having their visit to Operation ASHA linked to the contact who referred them, could present for screening and receive identical care without submitting the referral card. To the extent that this occurred, we will underestimate the extent of case finding as a result of the outreach and incentive conditions tested in this study.
After the intervention, endline surveys were conducted with existing patients to capture information on health outcomes and satisfaction with Operation ASHA. Intake surveys were also administered to the new suspects identified through the schemes: these measured their characteristics and history of care for TB.
World Bank Microdata Library
Name | Affiliation |
---|---|
Laura Natalia Becerra Luna | The World Bank Group |
Name | Affiliation | URL | |
---|---|---|---|
Strategic Impact Evaluation Fund | The World Bank Group | https://www.worldbank.org/en/programs/sief-trust-fund | siefimpact@worldbank.org |
Public Access
Use of the dataset must be acknowledged using a citation which would include:
Example:
Jessica Goldberg (University of Maryland), Mario Macis (Johns Hopkins University) and Pradeep Chintagunta (University of Chicago). India - Tuberculosis Social Network Project Impact Evaluation 2016-2017. Ref: IND_2016-2017_TBSNP-IE_v01_M. Dataset downloaded from [URL] on [date].
The user of the data acknowledges that the original collector of the data, the authorized distributor of the data, and the relevant funding agency bear no responsibility for use of the data or for interpretations or inferences based upon such uses.
Name | Affiliation | |
---|---|---|
Strategic Impact Evaluation Fund | The World Bank Group | siefimpact@worldbank.org |
DDI_IND_2016-2017_TBSNP-IE_v01_M_WB
Name | Affiliation | Role |
---|---|---|
Development Economics Data Group | The World Bank Group | Documentation of the study |
2023-09-28
Version 01 (September 2023)
This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.